영업이익률
2005년부터
계산
Edwards Lifesciences Corp., 영업이익률, 장기 추세계산
| 영업이익률 | = | 100 | × | 영업이익1 | ÷ | 순 매출액1 | |
|---|---|---|---|---|---|---|---|
| 2021. 12. 31. | 32.30% | = | 100 | × | 1,690,300) | ÷ | 5,232,500) |
| 2020. 12. 31. | 20.46% | = | 100 | × | 897,600) | ÷ | 4,386,300) |
| 2019. 12. 31. | 26.38% | = | 100 | × | 1,146,800) | ÷ | 4,348,000) |
| 2018. 12. 31. | 20.10% | = | 100 | × | 748,200) | ÷ | 3,722,800) |
| 2017. 12. 31. | 31.71% | = | 100 | × | 1,089,400) | ÷ | 3,435,300) |
| 2016. 12. 31. | 25.35% | = | 100 | × | 751,200) | ÷ | 2,963,700) |
| 2015. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 2,493,700) |
| 2014. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 2,322,900) |
| 2013. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 2,045,500) |
| 2012. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,899,600) |
| 2011. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,678,600) |
| 2010. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,447,000) |
| 2009. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,321,400) |
| 2008. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,237,700) |
| 2007. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,091,100) |
| 2006. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 1,037,000) |
| 2005. 12. 31. | 0.00% | = | 100 | × | —) | ÷ | 997,900) |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위 천
경쟁사와의 비교
Edwards Lifesciences Corp., 영업이익률, 장기 추세, 경쟁사와의 비교
| Edwards Lifesciences Corp. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|---|
| 2021. 12. 31. | 32.30% | 19.56% | 4.60% | 4.54% | 3.80% | 31.89% | 14.89% | 8.40% |
| 2020. 12. 31. | 20.46% | 15.48% | 5.12% | 5.19% | 6.56% | 24.09% | 16.57% | 8.76% |
| 2019. 12. 31. | 26.38% | 14.21% | 5.31% | 4.69% | 4.96% | 30.69% | 20.51% | 8.19% |
| 2018. 12. 31. | 20.10% | 11.94% | 8.82% | 2.07% | 5.50% | 32.21% | 22.20% | 7.71% |
| 2017. 12. 31. | 31.71% | 6.30% | 9.71% | 5.15% | 7.99% | 33.71% | 17.94% | 7.60% |
| 2016. 12. 31. | 25.35% | 15.27% | 0.00% | 5.84% | 3.22% | 34.95% | 18.35% | 7.03% |
| 2015. 12. 31. | 0.00% | 14.05% | 0.00% | 6.18% | 4.36% | 31.04% | 18.59% | 7.05% |
| 2014. 12. 31. | 0.00% | 12.84% | 0.00% | 6.31% | 4.91% | 25.56% | 22.42% | 7.92% |
| 2013. 12. 31. | 0.00% | 12.03% | 0.00% | 6.34% | 5.03% | 37.64% | 26.53% | 7.90% |
| 2012. 12. 31. | 0.00% | 20.28% | 0.00% | 5.87% | 5.20% | 40.30% | 0.00% | 8.42% |
| 2011. 12. 31. | 0.00% | 14.81% | 0.00% | 5.91% | 6.43% | 39.54% | 0.00% | 8.36% |
| 2010. 12. 31. | 0.00% | 17.31% | 0.00% | 6.39% | 5.53% | 39.29% | 0.00% | 8.41% |
| 2009. 12. 31. | 0.00% | 20.27% | 0.00% | 6.52% | 5.57% | 35.87% | 0.00% | 7.35% |
| 2008. 12. 31. | 0.00% | 19.28% | 0.00% | 6.91% | 3.74% | 35.53% | 0.00% | 6.54% |
| 2007. 12. 31. | 0.00% | 17.67% | 0.00% | 6.28% | 5.44% | 34.41% | 0.00% | 10.57% |
| 2006. 12. 31. | 0.00% | 9.09% | 0.00% | 5.57% | 3.91% | 28.81% | 0.00% | 9.88% |
| 2005. 12. 31. | 0.00% | 19.53% | 0.00% | 5.46% | 3.23% | 30.25% | 0.00% | 11.98% |
보고서 기준: 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).